Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

Indian firm develops two Zika vaccines By PBR Staff Writer
Indian firm Bharat Biotech has unveiled two vaccine candidates to protect humans against the mosquito-borne Zika virus, which was recently been recognized as a global emergency by the World Health Organization.
Drug Research > Drug Discovery & Development > News
Cloud Pharmaceuticals completes 17 computational drug discovery projects By PBR Staff Writer
Cloud Pharmaceuticals has completed 17 new computational drug discovery projects using its Quantum Molecular Design process to design molecules targeting a range of indications.
Drug Research > Drug Discovery & Development > News UK cancer drug developer Mission Therapeutics raises £60m in funding round By PBR Staff Writer
UK-based drug discovery and development firm Mission Therapeutics has raised £60m from investors and existing shareholders to advance its therapeutic programs.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
UK cancer drug developer Mission Therapeutics raises £60m in funding round
By PBR Staff Writer
UK-based drug discovery and development firm Mission Therapeutics has raised £60m from investors and existing shareholders to advance its therapeutic programs.
Drug Research > Drug Discovery & Development > News
Sanofi launches project to develop vaccine for Zika virus
By PBR Staff Writer
French drugmaker Sanofi has launched a project to develop a vaccine against the mosquito-borne Zika virus, which is being spread rapidly in several regions globally.
Drug Research > Drug Discovery & Development > News
Allergan, AstraZeneca sign antibiotic development deal
By PBR Staff Writer
Allergan and AstraZeneca have signed a global agreement to develop and commercialize ATM-AVI, a fixed-dose antibiotic combining aztreonam and avibactam, to treat serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens.
Drug Research > Drug Discovery & Development > News
EIB lends EUR20m to French biopharmaceutical firm Transgene
The European Investment Bank (EIB) and Transgene announced that they have entered into a EUR20m financing agreement.
Drug Research > Drug Discovery & Development > News
WHO warns Zika virus could affect four million people
By PBR Staff Writer
The World Health Organization (WHO) has said that the mosquito-borne Zika virus is spreading explosively and could affect three to four million people.
Drug Research > Drug Discovery & Development > News
Oxeia advances development of oxe-103 to treat concussions
Oxeia Biopharmaceuticals is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.
Drug Research > Drug Discovery & Development > News
Optum, PAREXEL partner to reduce drug development costs related with post-approval studies
Optum and PAREXEL International have formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted after the approval of a product to obtain further evidence of its safety or effectiveness.
Drug Research > Drug Discovery & Development > News
Acorda Therapeutics to buy Biotie Therapies
By PBR Staff Writer
Biotechnology firm Acorda Therapeutics has agreed to acquire Finnish drug development company Biotie Therapies for about $363m.
Drug Research > Drug Discovery & Development > News
International consortium secures Eurostars grant to develop novel treatment for clotting disorders
A grant for €1.9m has been awarded under the Eurostars programme to a consortium that comprises Abzena's subsidiary Antitope, Dutch biopharmaceutical companies Prothix and Aristi Biotech, the University Medical Center Utrecht (UMCU, the Netherlands) and French firm GenOway.
Drug Research > Drug Discovery & Development > News
NeuroVive Pharmaceutical acquires minority stake in Isomerase Therapeutics
By PBR Staff Writer
NeuroVive Pharmaceutical has acquired a 5% stake in the UK-based drug discovery and development firm Isomerase Therapeutics.
Drug Research > Drug Discovery & Development > News
View all Drug Discovery & Development news or find news targeted to your interests